Ancient Roman settlement uncovered after rare swords found near Cotswolds village
Archaeologists said their excavation had uncovered what could be evidence of a Roman villa.
It follows the discovery of two iron Roman cavalry swords, possibly displaying traces of their scabbards, during a metal detecting rally near Willersey two years ago.
Found by metal detectorist Glenn Manning, the swords were later donated to the Corinium Museum in Cirencester.
Mr Manning said: "Finding two swords in the same spot was amazing.
"The morning before the rally, I had a feeling I would find something special.
"This was only my second time metal detecting. I'm excited to find out more about them."
Historic England then carried out geophysical surveys of the area where the swords were found, which revealed the possibility of extensive prehistoric, and Romano-British remains.
Evidence of settlements spanning several centuries was then found during excavations earlier this year.
These include three or four Iron Age ring ditches, a substantial rectangular enclosure, and remains of Roman limestone buildings, which could be a winged villa.
Following more archaeological work, Historic England could then recommend to the Department for Culture, Media and Sport (DCMS) that the site be protected as a scheduled monument.
It is believed the long swords or "spatha" were used by the Romans on horseback from early in the second century AD through to the third century AD.
They are contemporary with the villa, but it is not known how they came to be there.
Ian Barnes, senior archaeologist at Historic England, said: "This excavation provides valuable insights into the nature of settlement patterns from the Early Iron Age through to the Roman period in Gloucestershire.
"This new evidence will help us to understand more about what happened around the period of the Roman Conquest, which must have been a tumultuous time."
Peter Busby, from Cotswold Archaeology, said: "I am very proud of how much our team of volunteers, professional archaeologists, and metal detectorists achieved in 15 days, despite the heavy January rain.
"We turned a ploughed field, the swords, and geophysical anomalies into the story of a settlement spanning hundreds of years - the first stage in telling the history of these fields and their cavalry swords."
Read more:
Emma Stuart, director of the Corinium Museum, added: "It's a privilege to acquire such rare artefacts.
"This valuable addition of Roman weaponry at the museum broadens the story of life in the Cotswolds during the mid to late Roman period."
The swords will be on display for public viewing at the Corinium Museum from 2 August.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
11 hours ago
- Yahoo
Google DeepMind has grand ambitions to ‘cure all diseases' with AI. Now, it's gearing up for its first human trials
Alphabet's Isomorphic Labs is preparing to launch human trials of AI-designed drugs, its president, Colin Murdoch, told Fortune. Born from DeepMind's AlphaFold breakthrough, the company is pairing cutting-edge AI with pharma veterans to design medicines faster, cheaper, and more accurately. Alphabet's secretive drug discovery arm, Isomorphic Labs, is getting ready to start testing its AI-designed drugs in humans, Colin Murdoch, Isomorphic Labs president and Google DeepMind's chief business officer, told Fortune. 'There are people sitting in our office in King's Cross, London, working, and collaborating with AI to design drugs for cancer,' Murdoch said during an interview in Paris. 'That's happening right now.' After years in development, Murdoch says human clinical trials for Isomorphic's AI-assisted drugs are finally in sight. 'The next big milestone is actually going out to clinical trials, starting to put these things into human beings,' he said. 'We're staffing up now. We're getting very close.' The company, which was spun out of DeepMind in 2021, was born from one of DeepMind's most celebrated breakthroughs, AlphaFold, an AI system capable of predicting protein structures with a high level of accuracy. Interactions of AlphaFold progressed from being able to accurately predict individual protein structures to modeling how proteins interact with other molecules like DNA and drugs. These leaps made it far more useful for drug discovery, helping researchers design medicines faster and more precisely, turning the tool into a launchpad for a much larger ambition. 'This was the inspiration for Isomorphic Labs,' Murdoch said of AlphaFold. 'It really demonstrates that we could do something very foundational in AI that could help unlock drug discovery.' In 2024, the same year it released AlphaFold 3, Isomorphic signed major research collaborations with pharma companies Novartis and Eli Lilly. A year later, in April 2025, Isomorphic Labs raised $600 million in its first-ever external funding round, led by Thrive Capital. The deals are part of Isomorphic's plan to build a 'world-class drug design engine,' a system that combines machine learning researchers with pharma veterans to design new medicines faster, more cheaply, and with a higher chance of success. As part of the deals with major pharma players, Isomorphic supports existing drug programs, but it also designs its own internal drug candidates in areas such as oncology and immunology, with the aim of eventually licensing them out after early-stage trials. 'We identify an unmet need, and we start our own drug design programs. We develop those, put them into human clinical trials… we haven't got that yet, but we're making good progress,' he said. Today, pharma companies often spend millions attempting to bring a single drug to market, sometimes with just a 10% chance of success once trials begin. Murdoch believes Isomorphic's tech could radically improve those odds. 'We're trying to do all these things: speed them up, reduce the cost, but also really improve the chance that we can be successful,' he says. He wants to harness AlphaFold's technology to get to a point where researchers have 100% conviction that the drugs they are developing are going to work in human trials. 'One day we hope to be able to say — well, here's a disease, and then click a button and out pops the design for a drug to address that disease,' Murdoch said. 'All powered by these amazing AI tools.' This story was originally featured on
Vogue
11 hours ago
- Vogue
It's Alive! Iris Van Herpen's Latest Innovation? A Dress Made From 125 Million Bioluminescent Algae
As fittings were underway on Saturday, Van Herpen and her latest collaborator, Chris Bellamy, gave Vogue a preview of the creation. Like some kind of otherworldly specimen on display, the dress and pant ensemble hung inside a box carefully controlled with light—exactly the wavelength where the algae are found 50 meters below sea level—and humidity, with a cloud of cold steam pooling around the base. Photo: Molly SJ Lowe/ Courtesy of Iris Van Herpen Photo: Molly SJ Lowe/ Courtesy of Iris Van Herpen In this daylight setting, the dimensional pattern was not illuminated, but milky white with a trace of blue; an imperfect comparison might be glow-in-the-dark stickers that have a greenish tinge. Like humans, pyrocystis lunula need 'sleep' and have their own light cycles like our Circadian rhythms. In the wild, they emit light in response to movement and/or when they sense predators. No word yet who Van Herpen is casting to wear the look or how the model will provoke the flash of light. Yet with Van Herpen standing on one side of the box and Bellamy on the other, they explained how they first connected in February, some two years after Bellamy began his research in French Polynesia (he still travels there while also working in France, the UK and Amsterdam, where Van Herpen is based). Once they agreed to advance on the project, Bellamy got to work on the algae farm—essentially a chamber of controlled light where the microorganisms grow in seawater, doubling in quantity every two weeks. After enough time, there was 20 liters of algae—a little more than a half-filled bathtub. Going from a liquid state to a solid that could be injected into Van Herpen's custom molds involved transferring the algae to a seaweed nutrient gel—some 50 were tested to arrive at the right texture, color, and overall balance—and coating the forms with a protective membrane that's breathable and allows them to live and glow. In total, this turned into a roughly 35-step process with support from the University of Amsterdam and the Francis Crick Institute for biomedical research. After significant trial and error, not to mention attaching the pattern to an illusion mesh second skin, they said they reached the successful outcome—'it worked,' said Bellamy—about a month ago. The garments are now stored according to precisely controlled conditions that correspond to the algae's native environment, such as temperature, light, humidity and rhythm. The organisms can continue to mate and reproduce inside the garment forms, making the dress brighter and brighter. As for an odor, Bellamy replies, 'No, you can just smell the seawater.'
Yahoo
12 hours ago
- Yahoo
Hello, summer! June solstice brings the start of summer, and the longest day of the year, to North America
When you buy through links on our articles, Future and its syndication partners may earn a commission. Update: Summer officially begins tonight in North America! Read on to find out exactly when and year on the summer solstice, revelers at Stonehenge in England stay up all night to celebrate the dawn of the longest day of the year in the Northern Hemisphere, with many images streamed live. But this year, there's a twist: The summer solstice there will occur on a different day than the solstice in North America, due to time zone differences. So when is the summer solstice in 2025, and what's the science behind it? This year, the summer solstice in the Northern Hemisphere occurs at 02:42 UTC on Saturday, June 21, 2025. That means it's at 10:42 p.m. EDT on Friday, June 20 and at 3:41 a.m. BST on Saturday, June 21. The event's name is instructive: "Sol" means "sun" in Latin, while "stice" means to stand still. That's exactly what appears to happen on two days each year — one between Dec. 20 and Dec. 22, and the other between June 20 and June 22 — when the sun rises and sets at its most northerly or southerly points on the horizon. If you consider the seasons and the sun's position in the sky, that checks out: The sun reaches its highest point in the midday sky in the Northern Hemisphere on the day of the summer solstice, which means it must be rising at its farthest northeast and setting at its farthest northwest. Precisely the opposite is happening in the Southern Hemisphere, where the June solstice is the winter solstice. When the sun is highest in the Northern Hemisphere's daytime sky, it's the lowest in the Southern Hemisphere's daytime sky. The situation is reversed for the December solstice, the longest day and the shortest night in the Southern Hemisphere. At the equinoxes ("equi" and "nox," meaning equal night), between March 19 and 21 and between Sept. 21 and 24, the sun appears to rise and set due east and west, respectively, from everywhere on Earth. Related: The 10 best stargazing events of 2025 RELATED STORIES —The 10 best stargazing events of 2025 —How does the summer solstice affect animals? —What color is the sun? Solstices and equinoxes happen because Earth's axis of rotation is tilted 23.5 degrees from the plane of its orbit around the sun, which causes the seasons. On the summer solstice, the Northern Hemisphere is tilted toward the sun, so it receives the full glare of the sun's rays for the longest time and the day is therefore the longest. Following this logic, it would seem that the summer solstice should also be the warmest day of the year. However, there's a slight seasonal lag because our mostly watery planet takes time to absorb the heat, according to the Royal Meteorological Society. At the North Pole, the sun does not set on the summer solstice, while at the South Pole, the sun does not note: This article was updated on June 20 to mark the beginning of the summer solstice in North America.
